BIOLASE (BIOL) Downgraded by Zacks Investment Research to Hold

BIOLASE stock has undergone multiple analysts rating changes in the recent past.  BIOLASE Downgraded by Zacks Investment Research on 10/13/2021. In a note to investors, the firm issued a new rating of Hold. The analysts previously had rating of Buy.

Shares of BIOLASE traded down -$0.01 on Wednesday, reaching $0.61. 1074087 shares of the stock traded hands, compared to its average volume of 1512169. Shares of BIOLASE were trading at $0.61 on Wednesday. The firm’s 50 day moving average is $0.67 and its 200 day moving average is $0.78.BIOLASE has a 12 month low of $0.61 and a 12 month high of $1.51. While on yearly highs and lows, BIOLASE’s today has traded high as $0.63 and has touched $0.61 on the downward trend. See More Analyst Rating at: RATING

BIOLASE Earnings and What to expect: 

BIOLASE last released its quarterly earnings data on August 11th, 2021. The medical technology company reported ($0.02) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.04) by $0.02. The business earned $9.13 million during the quarter. BIOLASE has generated ($0.56) earnings per share over the last year (($0.34) diluted earnings per share). Earnings for BIOLASE are expected to grow in the coming year, from ($0.11) to ($0.08) per share. BIOLASE has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Thursday, November 11th, 2021 based off prior year’s report dates.

Earnings for BIOLASE are expected to grow in the coming year, from ($0.11) to ($0.08) per share. The P/E ratio of BIOLASE is -1.81, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. The P/E ratio of BIOLASE is -1.81, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. BIOLASE has a P/B Ratio of 5.58. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

BIOLASE (BIOL) Moving Average Technical Analysis

5 day Moving Average is $0.62 And 5 day price change is $0.01 (1.87%)  with average volume for 5 day average is 1,232,320. While technical analysis for average 20 days shows significant difference, 20 day moving average is  $0.64 and 20 day price change is -$0.06 (-8.80%) and average 20 day moving volume is 1,273,870. 50 day moving average is $0.67  and 50 day price change is $0.04 ( 6.17%)  and with average volume for 50 days is : 4,849,060. 200 day moving average is $0.78  and 200 day price change is $0.13 (27.96%)  and with average volume for 200 days is : 13,600,696.

Other owners latest trading in BIOLASE :

  • On 9/17/2021 shares held by Virtu Financial LLC were 220,473 which equates to market value of $0.15M and appx 0.00% owners of BIOLASE
  • On 8/16/2021 shares held by State Street Corp were 541,194 which equates to market value of $0.38M and appx 0.00% owners of BIOLASE
  • On 8/16/2021 shares held by Goldman Sachs Group Inc. were 172,521 which equates to market value of $0.12M and appx 0.00% owners of BIOLASE
  • In total Institutional ownership equates to Institutional Ownership Percentage: 11.56% for BIOLASE

See More Analyst Rating at: RATING